PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 • CROs – Market size and forecast 2017-2022 • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Rise in investment in R&D • Rise in production of vaccines • Increasing outsourcing of analytical testing services PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Catalent • Charles River • Eurofins Scientific • Merck KGaA • SGS PART 15: APPENDIX • List of abbreviations Exhibit 01: Related market Exhibit 02: Market characteristics Exhibit 03: Market segments Exhibit 04: Market definition - Inclusions and exclusions checklist Exhibit 05: Market size 2017 Exhibit 06: Validation techniques employed for market sizing 2017 Exhibit 07: Global biopharmaceutical analytical testing services market – Market size and forecast 2017-2022 ($ mn) Exhibit 08: Global biopharmaceutical analytical testing services market – Year-over-year growth 2018-2022 (%) Exhibit 09: Five forces analysis 2017 Exhibit 10: Five forces analysis 2022 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2017 Exhibit 17: Customer landscape Exhibit 18: End-user – Market share 2017-2022 (%) Exhibit 19: Comparison by end-user Exhibit 20: Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Pharmaceutical and biotechnology companies – Year-over-year growth 2018-2022 (%) Exhibit 22: CROs – Market size and forecast 2017-2022 ($ mn) Exhibit 23: CROs – Year-over-year growth 2018-2022 (%) Exhibit 24: Market opportunity by end-user Exhibit 25: Global biopharmaceutical analytical testing services market – Market share by geography 2017-2022 (%) Exhibit 26: Regional comparison Exhibit 27: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 28: Americas – Year-over-year growth 2018-2022 (%) Exhibit 29: Top 3 countries in Americas Exhibit 30: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 31: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 32: Top 3 countries in EMEA Exhibit 33: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 34: APAC – Year-over-year growth 2018-2022 (%) Exhibit 35: Top 3 countries in APAC Exhibit 36: Market opportunity Exhibit 37: Some therapeutic applications of mAbs Exhibit 38: Exhibit 18: List of bioterrorism agents and their threat category Exhibit 39: Vendor landscape Exhibit 40: Landscape disruption Exhibit 41: Vendors covered Exhibit 42: Vendor classification Exhibit 43: Market positioning of vendors Exhibit 44: Catalent overview Exhibit 45: Catalent – Business segments Exhibit 46: Catalent – Organizational developments Exhibit 47: Catalent – Geographic focus Exhibit 48: Catalent – Segment focus Exhibit 49: Catalent – Key offerings Exhibit 50: Vendor overview Exhibit 51: Charles River – Business segments Exhibit 52: Charles River – Organizational developments Exhibit 53: Charles River – Geographic focus Exhibit 54: Charles River – Segment focus Exhibit 55: Charles River – Key offerings Exhibit 56: Eurofins Scientific overview Exhibit 57: Eurofins Scientific – Business segments Exhibit 58: Eurofins Scientific – Organizational developments Exhibit 59: Eurofins Scientific – Geographic focus Exhibit 60: Eurofins Scientific – Segment focus Exhibit 61: Eurofins Scientific – Key offerings Exhibit 62: Merck KGaA overview Exhibit 63: Merck KGaA – Business segments Exhibit 64: Merck KGaA – Organizational developments Exhibit 65: Merck KGaA – Geographic focus Exhibit 66: Merck KGaA – Segment focus Exhibit 67: Merck KGaA – Key offerings Exhibit 68: SGS overview Exhibit 69: SGS – Business segments Exhibit 70: SGS – Organizational developments Exhibit 71: SGS – Geographic focus Exhibit 72: SGS – Segment focus Exhibit 73: SGS – Key offerings

Catalent Charles River Eurofins Scientific Merck KGaA SGS